MRI-Visible Prostate Tumour
Cross-source consensus on MRI-Visible Prostate Tumour from 1 sources and 5 claims.
1 sources · 5 claims
How it works
Dosage & preparation
Preparation
Where it comes from
Highlighted claims
- The MRI-visible tumor is contoured using biparametric or multiparametric MRI to define gross tumor volume. — Dose dE-eScalaTion IN prostATe radIOtherapy usiNg an MR-Linac in 2 Fractions (DESTINATION 2): protocol for a randomised, phase II/R-IDEAL2b trial
- In the de-escalated arm, the gross tumor volume receives a 4 mm margin cropped at the prostate capsule. — Dose dE-eScalaTion IN prostATe radIOtherapy usiNg an MR-Linac in 2 Fractions (DESTINATION 2): protocol for a randomised, phase II/R-IDEAL2b trial
- The 4 mm margin is intended to balance microscopic extension coverage against overtreatment. — Dose dE-eScalaTion IN prostATe radIOtherapy usiNg an MR-Linac in 2 Fractions (DESTINATION 2): protocol for a randomised, phase II/R-IDEAL2b trial
- Clinically significant prostate tumor burden is concentrated in MRI-visible lesions according to the article's rationale. — Dose dE-eScalaTion IN prostATe radIOtherapy usiNg an MR-Linac in 2 Fractions (DESTINATION 2): protocol for a randomised, phase II/R-IDEAL2b trial
- Intraprostatic recurrence usually occurs at the original tumor site. — Dose dE-eScalaTion IN prostATe radIOtherapy usiNg an MR-Linac in 2 Fractions (DESTINATION 2): protocol for a randomised, phase II/R-IDEAL2b trial